Have questions, want to collaborate, or need resources on cardiac amyloidosis in Africa? We’d love to hear from you.Reach out and let’s move this mission forward, together.
Amyloidosis Africa a été fondée pour répondre à une crise sanitaire silencieuse : le sous-diagnostic largement répandu de l’amylose cardiaque à travers le continent. Issue d’une collaboration entre des cardiologues africains de premier plan et soutenue par des organisations telles que CRK Clinical Research Key, notre initiative est née d’une vision commune : garantir des soins équitables pour chaque cœur.
Des campagnes de sensibilisation à la recherche transfrontalière et à la formation des cliniciens, nous continuons à bâtir un réseau qui renforce les capacités des patients, des professionnels de santé et des décideurs, en apportant à l’Afrique le soutien dont elle a besoin, là où il est le plus nécessaire.
Nous proposons une formation médicale fondée sur des données probantes aux professionnels de santé à travers l’Afrique afin de renforcer le diagnostic précoce et d’améliorer les résultats pour les patients.
VIEW DETAILSNATIONS
Chez Amyloidosis Africa, nous croyons que chaque vie mérite une chance de se battre, indépendamment de la géographie ou du revenu. Notre action s’étend à travers le continent afin de garantir que l’amylose cardiaque soit reconnue, diagnostiquée et traitée à temps.
Nous construisons des passerelles entre les professionnels de santé, les chercheurs et les communautés, en créant un changement durable grâce à la sensibilisation, la formation et l’accès aux soins.
Personne ne devrait souffrir en silence d’une maladie qui peut être détectée et prise en charge avec les bons outils. Ensemble, nous façonnons l’avenir de la santé cardiaque en Afrique.

We provide clinicians and communities with educational tools, awareness resources, and ongoing training to better identify and understand cardiac amyloidosis.

We connect patients, families, and healthcare providers with the knowledge and partnerships they need, offering guidance throughout the diagnostic and care journey.

We advocate for access to early testing, accurate diagnosis, and treatment pathways, bridging gaps in care through collaboration across Africa.
Interested in partnering on studies, co-authoring papers, or joining our pan-African working groups? Fill out the form below and our team will get in touch.
Cardiac amyloidosis remains under-recognized. We drive awareness at the national and local level.
Workshops and CME programs empower African doctors to detect and manage hATTR-CM effectively.
We support hospital-based research and surveys to map disease burden and care access.
Continental collaboration helps accelerate trials and produce Africa-led scientific data.
We equip patients and families with trusted resources for early care-seeking and diagnosis.
We collaborate with health ministries and societies to shape protocols for diagnosis and treatment.
Cardiac amyloidosis is often misdiagnosed or missed entirely. Become a voice in your hospital, city, or community, educate others and help connect lives to life-saving care. Simple actions like sharing resources, organizing talks, or hosting CME sessions create real change.
IN TARGET REGIONS

For too long, patients across Africa have died undiagnosed. Amyloidosis Africa exists to change that through clinician education and regional collaboration.

We are building a continent-wide network of cardiologists committed to improving care for patients with amyloidosis. This collaboration is long overdue, and absolutely necessary.

For too long, patients across Africa have died undiagnosed. Amyloidosis Africa exists to change that through clinician education and regional collaboration.

Recognizing the red flags of amyloidosis early can save lives. We’re empowering frontline healthcare providers with the tools to do just that.

Cardiac amyloidosis is no longer a rare disease, it’s a rarely diagnosed one. Through Amyloidosis Africa, we are reshaping how Africa detects and manages this hidden epidemic.

We are building a continent-wide network of cardiologists committed to improving care for patients with amyloidosis. This collaboration is long overdue, and absolutely necessary.

For too long, patients across Africa have died undiagnosed. Amyloidosis Africa exists to change that through clinician education and regional collaboration.

Recognizing the red flags of amyloidosis early can save lives. We’re empowering frontline healthcare providers with the tools to do just that.
Amyloidosis in Africa is not rare; it is rarely recognized. By raising awareness and strengthening diagnosis, we can change outcomes for thousands of patients who are currently invisible.
Cardiac amyloidosis remains an underappreciated cause of heart failure in Africa. Improving clinical suspicion and access to diagnosis is essential to advancing cardiovascular care on the continent.
In many African countries, amyloidosis is diagnosed too late or not at all. Regional collaboration and education are key to closing this critical gap in cardiac care.
Amyloidosis is a global disease with a significant but overlooked presence in Africa. Early recognition and structured diagnostic pathways can dramatically improve patient survival and quality of life.
In many African countries, amyloidosis is diagnosed too late or not at all. Regional collaboration and education are key to closing this critical gap in cardiac care.
Cardiac amyloidosis is an important but often overlooked cause of heart failure in Africa. Strengthening clinician awareness and diagnostic pathways will allow us to identify patients earlier and deliver more effective care.







Stay informed with the latest articles, updates, and announcements from Amyloidosis Africa. Explore insights on research, awareness initiatives, medical education, and events advancing the diagnosis and care of amyloidosis across Africa
Address : Nairobi, Kenya
Email : contact@amyloidosisafrica.org
Timing : 09 am to 10 pm
We advance cardiac amyloidosis care across Africa through collaboration, training, and research. Join us to change the future of heart health and empower local clinicians with knowledge and tools.